Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Carcinoma, Non-Small Cell Lung Cancer (NSCLC)”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT00807573
What this trial is testing

Paclitaxel, Bevacizumab and Pemetrexed in Patients With Untreated, Advanced Non-Small Cell Lung Cancer Using Web-Based Data Collection, Patient Self-Reporting of Adverse Effects and Automated Response Assessment

Who this might be right for
Lung Cancer
Memorial Sloan Kettering Cancer Center 44
Early research (Phase 1)Study completedNCT04803305
What this trial is testing

Study to Compare the Effects of Repeated Doses of an Investigational New Drug and a Placebo on Appetite in Advanced Cancer and Anorexia

Who this might be right for
Non-small Cell Lung CancerPancreatic CancerColorectal Cancer+7 more
Pfizer 18
Testing effectiveness (Phase 2)Ended earlyNCT03330405
What this trial is testing

Javelin Parp Medley: Avelumab Plus Talazoparib In Locally Advanced Or Metastatic Solid Tumors

Who this might be right for
Avelumab in Combination With Talazoparib Will be Investigated in Patients With Locally Advanced (Primary or Recurrent) or Metastatic Solid Tumors
Pfizer 223
Early research (Phase 1)WithdrawnNCT03245177
What this trial is testing

Pembrolizumab in Combination With Radiotherapy in Locally Advanced Non-Small Cell Lung Cancer (NSCLC)

Who this might be right for
Non Small Cell Lung Cancer
Prof Corinne Faivre-Finn
Early research (Phase 1)Study completedNCT03735628
What this trial is testing

Evaluate the Safety and Efficacy of Copanlisib in Combination With Nivolumab in Patients With Advanced Solid Tumors

Who this might be right for
Non-small Cell Lung Cancer (NSCLC)Head and Neck Squamous Cell Carcinoma (HNSCC)Hepatocellular Carcinoma (HCC)
Bayer 16
Testing effectiveness (Phase 2)Study completedNCT00191139
What this trial is testing

Gemcitabine or Gemcitabine Plus Docetaxel After Cisplatin, Etoposide and Radiation in Non Small Cell Lung Cancer (NSCLC)

Who this might be right for
Non-small Cell Lung Cancer
Eli Lilly and Company 64
Testing effectiveness (Phase 2)Study completedNCT01750281
What this trial is testing

Assess Efficacy and Safety of AZD6244 in Combination With Docetaxel in Patients Receiving Second Line Non Small Cell Lung Cancer Treatment.

Who this might be right for
Locally Advanced or Metastatic Non Small Cell Lung Cancer Stage IIIb - IV
AstraZeneca 212
Testing effectiveness (Phase 2)Looking for participantsNCT04332367
What this trial is testing

Carboplatin, Taxane And Ramucirumab for Patients With NSCLC After Pemetrexed or Pembrolizumab Maintenance

Who this might be right for
Non-small Cell Lung Cancer
Abramson Cancer Center at Penn Medicine 59
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06851169
What this trial is testing

This is a Two-cohort, Exploratory Clinical Study Assessing the Activity of Benmelstobart Alone or Combined with Anlotinib Administered Prior to Surgery in Terms of Pathological Complete Response

Who this might be right for
Non Small Cell Lung Cancer
Tang-Du Hospital 58
Testing effectiveness (Phase 2)Ended earlyNCT01138722
What this trial is testing

Predicting Cell Death by Radiation Therapy in Early Stage Non-small Cell Lung Cancer: a Prospective Translational Trial

Who this might be right for
Early Stage Non-small Cell Lung Cancer
University Hospital, Ghent 1
Testing effectiveness (Phase 2)Study completedNCT02276027
What this trial is testing

A Phase II, Open Label, Multiple Arm Study of AUY922, BYL719, INC280, LDK378 and MEK162 in Chinese Patients With Advanced Non-small Cell Lung Cancer

Who this might be right for
Adenocarcinoma Lung Cancer; Squamous Cell Lung Carcinoma
Novartis Pharmaceuticals 66
Testing effectiveness (Phase 2)Study completedNCT03102242
What this trial is testing

Atezolizumab Immunotherapy in Patients With Advanced NSCLC

Who this might be right for
Carcinoma, Non-Small-Cell Lung
Alliance Foundation Trials, LLC. 64
Not applicableNot Yet RecruitingNCT07760519
What this trial is testing

Observational PMS Study Assessing Durvalumab Safety in Indian Adults With Resectable NSCLC

Who this might be right for
Carcinoma, Non-Small-Cell Lung
AstraZeneca 78
Testing effectiveness (Phase 2)UnknownNCT03830411
What this trial is testing

Sintilimab Compared With Docetaxel or Pemetrexed as Second-line Treatment for Patients With Stage IV Nonsquamous Non-small Cell Lung Cancer After Failure With Platinum-Containing Chemotherapy

Who this might be right for
Nonsquamous Non-Small Cell Lung Cancer
Xin-Hua Xu 76
Testing effectiveness (Phase 2)Study completedNCT00745875
What this trial is testing

ZD4054 (Zibotentan) Phase II Non-Small Cell Lung Cancer Study

Who this might be right for
Non Small Cell Lung CancerLung Cancer
AstraZeneca 66
Early research (Phase 1)Study completedNCT06221475
What this trial is testing

Learn How BAY2927088 is Taken up and Handled by the Body in Healthy Male Participants

Who this might be right for
Advanced Non-small Cell Lung CancerEGFR MutationHER2 Mutation+1 more
Bayer 8
Testing effectiveness (Phase 2)UnknownNCT02535507
What this trial is testing

Efficacy and Safety of Pyrotinib in Patients With HER2 Mutation Advanced Non-Small Cell Lung Cancer

Who this might be right for
Non-small Cell Lung Cancer
Tongji University 40
Not applicableStudy completedNCT00483639
What this trial is testing

Study of Anxiety and Avoidance of Others in Patients Previously Treated for Head and Neck Cancer

Who this might be right for
Anxiety DisorderHead and Neck CancerLung Cancer
Vanderbilt-Ingram Cancer Center 100
Post-approval studies (Phase 4)Study completedNCT00883675
What this trial is testing

Safety Study of Adjuvant Docetaxel-Carboplatin Treatment for Resected Lung Cancer

Who this might be right for
Non-small Cell Lung Cancer
Michael Mann 133
Testing effectiveness (Phase 2)Active Not RecruitingNCT04083599
What this trial is testing

GEN1042 Safety Trial and Anti-tumor Activity in Participants With Malignant Solid Tumors

Who this might be right for
Malignant Solid TumorNon-Small Cell Lung Cancer (NSCLC)Colorectal Cancer (CRC)+3 more
Genmab 350
Next Page